Duke tongue cancer treatment combines cutting-edge precision therapies with the extensive experience of Duke Health’s multidisciplinary team. Patients receive coordinated care from otolaryngology, medical oncology, radiation oncology, and speech pathology specialists focused on preserving function and improving survival.
This overview highlights how Duke tailors surgery, radiation, chemotherapy, and immunotherapy to the stage and location of tongue cancer. The following sections detail diagnostic pathways, treatment modalities, symptom management, and long-term follow-up expectations.
| Treatment Modality | When Used | Goal | Potential Side Effects |
|---|---|---|---|
| Transoral Robotic Surgery (TORS) | Early-stage and select advanced tumors | Complete tumor removal with minimal tissue disruption | Swelling, temporary voice changes, bleeding |
| Radiation Therapy | Postoperative adjuvant or definitive nonsurgical treatment | Eradicate residual cancer and control local disease | Sore throat, dry mouth, taste changes, fatigue |
| Chemotherapy | Combined with radiation for advanced disease or metastasis | Shrink tumors and eliminate microscopic spread | Nausea, low blood counts, hair loss, kidney effects |
| Immunotherapy | Recurrent or metastatic cases after prior therapies | Activate the immune system to target cancer cells | Fatigue, rash, immune-related organ inflammation |
Diagnostic Evaluation and Staging at Duke
Comprehensive Assessment
At Duke, diagnosis begins with a thorough head and neck exam and often an endoscopy to visualize the tumor. Biopsy confirms cancer type, while imaging such as MRI, CT, and PET defines the stage and guides treatment planning.
Speech and Swallowing Function
Pre-treatment evaluation by speech-language pathologists establishes baseline swallowing and voice function. This information helps the team balance cancer control with preservation of quality of life after therapy.
Surgical Management and Functional Outcomes
Minimally Invasive Approaches
For suitable tumors, Duke surgeons use transoral robotic and endoscopic techniques to remove cancer through the mouth, avoiding external incisions when possible. This approach can reduce hospital stay and speed recovery.
Reconstruction and Rehabilitation
When larger tissue defects remain, microvascular reconstruction using tissue from other body sites helps restore form and function. Postoperative speech and swallowing therapy supports functional recovery and safe oral intake.
Radiation Oncology and Precision Delivery
Intensity-Modulated Radiation Therapy (IMRT)
IMRT and related techniques allow Duke’s radiation team to sculpt high-dose regions to the tumor while sparing saliva glands, swallowing structures, and critical nerves. This reduces long-term dry mouth and swallowing difficulties.
Brachytherapy and Clinical Trials
Select patients may be eligible for brachytherapy or participation in trials testing novel combinations of radiation, targeted agents, and immunotherapies. Duke’s active research program provides access to emerging strategies close to standard care.
Medical Oncology, Systemic Therapy, and Supportive Care
Concurrent Chemoradiation and Induction Chemotherapy
For advanced disease, Duke often combines chemotherapy with radiation to improve tumor control. In some cases, induction chemotherapy shrinks the tumor upfront, helping to preserve organ function and avoid more extensive surgery.
Immunotherapy and Targeted Approaches
Patients with recurrent or metastatic disease may receive immune checkpoint inhibitors or targeted agents based on tumor biomarkers. Duke’s multidisciplinary clinics coordinate medical, supportive, and palliative care to manage symptoms and maintain quality of life.
Personalized Follow-Up and Survivorship at Duke
- Regular imaging and clinic exams to monitor for recurrence
- Ongoing speech and swallowing therapy to optimize function
- Dental and oral health support to manage treatment-related changes
- Nutritional counseling and strategies for safe eating
- Access to psychological support and survivorship programs
- Coordination with primary care for overall health maintenance
FAQ
Reader questions
How does speech function change after transoral robotic surgery at Duke?
Many patients experience temporary voice changes, such as hoarseness or fatigue, which typically improve over weeks to months with speech therapy. Permanent changes are uncommon when speech structures are carefully preserved during surgery.
Can radiation therapy cause long-term dry mouth at Duke’s head and neck program?
Yes, dry mouth is a common long‑term side effect when salivary glands are in the treatment field. Duke uses saliva-sparing techniques, artificial saliva products, and proactive dental care to help minimize discomfort and reduce tooth decay risk.
What role does immunotherapy play in recurrent tongue cancer at Duke Health?
For recurrent or metastatic cases, Duke may offer immunotherapy after prior therapies, especially if the tumor tests positive for PD-L1 or high tumor mutational burden. Responses can be durable, and close monitoring for immune-related side effects is part of standard care. Recovery after TORS is generally faster, with shorter hospital stays and quicker return to normal swallowing and speech. Open procedures may require neck incisions and longer rehabilitation, but the surgical team selects the approach that best balances cancer control and quality of life for each patient.